In type 1 diabetes (T1D), the autoantigens in the pancreas are presented by major histocompatibility complex (MHC) molecules that activate diabetogenic T cells and play important roles in the destruction of pancreatic insulin (Ins)-producing β cells. Here, INS is linked to type 1 diabetes mellitus.